San Antonio Methodist TX Transplant Physicians Group

San Antonio, Texas 78229-3771

2 studies enrolling now · 3 studies all time

What they study most

Acute Leukemia, Multiple Myeloma, Pulmonary Arterial Hypertension

Studies at this site

• A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) — Recruiting now
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)